These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 9736590

  • 1. Presence of tissue factor pathway inhibitor in human atherosclerotic plaques is associated with reduced tissue factor activity.
    Caplice NM, Mueske CS, Kleppe LS, Simari RD.
    Circulation; 1998 Sep 15; 98(11):1051-7. PubMed ID: 9736590
    [Abstract] [Full Text] [Related]

  • 2. Expression, localization, and activity of tissue factor pathway inhibitor in normal and atherosclerotic human vessels.
    Crawley J, Lupu F, Westmuckett AD, Severs NJ, Kakkar VV, Lupu C.
    Arterioscler Thromb Vasc Biol; 2000 May 15; 20(5):1362-73. PubMed ID: 10807755
    [Abstract] [Full Text] [Related]

  • 3. Co-localization of tissue factor and tissue factor pathway inhibitor in coronary atherosclerosis.
    Kaikita K, Takeya M, Ogawa H, Suefuji H, Yasue H, Takahashi K.
    J Pathol; 1999 Jun 15; 188(2):180-8. PubMed ID: 10398162
    [Abstract] [Full Text] [Related]

  • 4. Tissue factor, tissue factor pathway inhibitor and vascular endothelial growth factor-A in carotid atherosclerotic plaques.
    Migdalski A, Kotschy M, Jawien A.
    Eur J Vasc Endovasc Surg; 2005 Jul 15; 30(1):41-7. PubMed ID: 15933981
    [Abstract] [Full Text] [Related]

  • 5. Circulating monocytes mirror the imbalance in TF and TFPI expression in carotid atherosclerotic plaques with lipid-rich and calcified morphology.
    Basavaraj MG, Sovershaev MA, Egorina EM, Gruber FX, Bogdanov VY, Fallon JT, Østerud B, Mathiesen EB, Hansen JB.
    Thromb Res; 2012 Apr 15; 129(4):e134-41. PubMed ID: 22178066
    [Abstract] [Full Text] [Related]

  • 6. Dyslipidemia shifts the tissue factor/tissue factor pathway inhibitor balance toward increased thrombogenicity in atherosclerotic plaques: evidence for a corrective effect of statins.
    Zawadzki C, Susen S, Richard F, Haulon S, Corseaux D, Jeanpierre E, Vincentelli A, Lucas C, Torpier G, Martin A, Van Belle E, Staels B, Jude B.
    Atherosclerosis; 2007 Dec 15; 195(2):e117-25. PubMed ID: 17196206
    [Abstract] [Full Text] [Related]

  • 7. Tissue factor pathway inhibitor expression in atherosclerosis.
    Drew AF, Davenport P, Apostolopoulos J, Tipping PG.
    Lab Invest; 1997 Oct 15; 77(4):291-8. PubMed ID: 9354763
    [Abstract] [Full Text] [Related]

  • 8. Carotid atherosclerosis. Immunocytochemical analysis of the vascular and cellular composition in endarterectomies.
    Milei J, Parodi JC, Fernandez Alonso G, Barone A, Beigelman R, Ferreira LM, Arrigoni G, Matturri L.
    Cardiologia; 1996 Jun 15; 41(6):535-42. PubMed ID: 8766416
    [Abstract] [Full Text] [Related]

  • 9. Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques: effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions.
    Badimon JJ, Lettino M, Toschi V, Fuster V, Berrozpe M, Chesebro JH, Badimon L.
    Circulation; 1999 Apr 13; 99(14):1780-7. PubMed ID: 10199872
    [Abstract] [Full Text] [Related]

  • 10. Increased expression of TFPI in human carotid stenosis.
    Stavik B, Holm S, Espada S, Iversen N, Sporsheim B, Bjerkeli V, Dahl TB, Sandset PM, Skjelland M, Espevik T, Skretting G, Halvorsen B.
    Thromb Res; 2017 Jul 13; 155():31-37. PubMed ID: 28482260
    [Abstract] [Full Text] [Related]

  • 11. Influence of blockade at specific levels of the coagulation cascade on restenosis in a rabbit atherosclerotic femoral artery injury model.
    Jang Y, Guzman LA, Lincoff AM, Gottsauner-Wolf M, Forudi F, Hart CE, Courtman DW, Ezban M, Ellis SG, Topol EJ.
    Circulation; 1995 Nov 15; 92(10):3041-50. PubMed ID: 7586275
    [Abstract] [Full Text] [Related]

  • 12. Immunology of atherosclerosis. Demonstration of heat shock protein 60 expression and T lymphocytes bearing alpha/beta or gamma/delta receptor in human atherosclerotic lesions.
    Kleindienst R, Xu Q, Willeit J, Waldenberger FR, Weimann S, Wick G.
    Am J Pathol; 1993 Jun 15; 142(6):1927-37. PubMed ID: 8099471
    [Abstract] [Full Text] [Related]

  • 13. [Value of plasma tissue factor, tissue factor pathway inhibitor and factor VII assessments in patients with acute myocardial and cerebral infarction].
    Xiong SL, Wang Q, Zheng L, Li JL, Wen ZB, He SL.
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Dec 15; 27(12):1821-3. PubMed ID: 18158992
    [Abstract] [Full Text] [Related]

  • 14. Structural requirements for TFPI-mediated inhibition of neointimal thickening after balloon injury in the rat.
    Han X, Girard TJ, Baum P, Abendschein DR, Broze GJ.
    Arterioscler Thromb Vasc Biol; 1999 Oct 15; 19(10):2563-7. PubMed ID: 10521388
    [Abstract] [Full Text] [Related]

  • 15. Levels of factor VIIc associated with decreased tissue factor pathway inhibitor and increased plasminogen activator inhibitor-1 in dyslipidemias.
    Zitoun D, Bara L, Basdevant A, Samama MM.
    Arterioscler Thromb Vasc Biol; 1996 Jan 15; 16(1):77-81. PubMed ID: 8548430
    [Abstract] [Full Text] [Related]

  • 16. Deficiency of tissue factor pathway inhibitor promotes atherosclerosis and thrombosis in mice.
    Westrick RJ, Bodary PF, Xu Z, Shen YC, Broze GJ, Eitzman DT.
    Circulation; 2001 Jun 26; 103(25):3044-6. PubMed ID: 11425765
    [Abstract] [Full Text] [Related]

  • 17. Changes of plasma tissue factor and tissue factor pathway inhibitor antigen levels and induction of tissue factor expression on the monocytes in coronary artery disease.
    Kim HK, Song KS, Park YS, Yun YS, Shim WH.
    Cardiology; 2000 Jun 26; 93(1-2):31-6. PubMed ID: 10894904
    [Abstract] [Full Text] [Related]

  • 18. Extrahepatic synthesis of factor VII in human atherosclerotic vessels.
    Wilcox JN, Noguchi S, Casanova J.
    Arterioscler Thromb Vasc Biol; 2003 Jan 01; 23(1):136-41. PubMed ID: 12524237
    [Abstract] [Full Text] [Related]

  • 19. [Change of tissue factor pathway ratio during attack in patients with acute myocardial infarction and its clinical significance].
    Wang R, Wen BZ, Ma YT, Peng -, Li H, Zhong D, Li L.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb 01; 17(1):198-202. PubMed ID: 19236778
    [Abstract] [Full Text] [Related]

  • 20. Tissue factor pathway inhibitor binds to platelet thrombospondin-1.
    Mast AE, Stadanlick JE, Lockett JM, Dietzen DJ, Hasty KA, Hall CL.
    J Biol Chem; 2000 Oct 13; 275(41):31715-21. PubMed ID: 10922378
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.